Data as of 3:59pm ET
| -0.30 / -0.65%|
The 17 analysts offering 12-month price forecasts for Novozymes A/S have a median target of 45.02, with a high estimate of 51.82 and a low estimate of 37.10. The median estimate represents a -2.50% decrease from the last price of 46.18.
The current consensus among 18 polled investment analysts is to Hold stock in Novozymes A/S. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.